The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials.
about
Patient considerations in metastatic colorectal cancer - role of panitumumab.CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab.Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis.The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China.Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case reviewOff-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis.From conventional chemotherapy to targeted therapy: use of monoclonal antibodies (moAbs) in gastrointestinal (GI) tumors.The use of EGFR inhibitors in colorectal cancer: is it clinically efficacious and cost-effective?Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patients.Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies.The safety of monoclonal antibodies for treatment of colorectal cancer.On-treatment markers as predictors to guide anti-EGFR MoAb treatment in metastatic colorectal cancer: a systematic review with meta-analysis.Cutaneous Toxicities of Molecular Targeted Therapies.Expression of P-EGFR and P-Akt protein in esophageal squamous cell carcinoma and its prognosis.Capecitabine-induced radiation recall phenomenon: a case report.Preventing or treating anti-EGFR related skin rash with antibiotics?Hypomagnesemia and clinical benefits of anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer: a systematic review and meta-analysis.The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17.A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer.Incidence, risk and prognostic role of anti-epidermal growth factor receptor-induced skin rash in biliary cancer: a meta-analysis.Prolonged Overall Treatment Time and Lack of Skin Rash Negatively Impact Overall Survival in Locally Advanced Head and Neck Cancer Patients Treated with Radiotherapy and Concomitant Cetuximab.Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer.Risk of anti-EGFR monoclonal antibody-related skin rash: an up-to-date meta-analysis of 25 randomized controlled trials.Association between EGFR gene polymorphisms, skin rash and response to anti-EGFR therapy in metastatic colorectal cancer patients.Assessment of demodex presence in acne-like rash associated with cetuximab.EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs.Predictive role of skin rash in advanced pancreatic cancer patients treated with gemcitabine plus erlotinib: a systematic review and meta-analysisThe Winding Roadmap of Biomarkers toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer
P2860
Q33563293-6E8B2617-9C5A-4CD2-94B3-E1DF559022E2Q36012730-05F4D936-A327-4A7E-9D1A-1B9FBE03EA4FQ36026706-ABB4F0F7-0038-4115-9883-62C3A6EA0E3AQ37226025-F0F217C5-34A5-43D7-860F-4DFD97ED4601Q37369678-8D82F754-17F5-4F9E-8ED8-87FD8FE1AAC8Q37737863-51644E50-ABA5-4E04-A6CE-7B47E35B22A7Q38234000-1AC09C02-2107-4C60-8FCF-7A3B05580A3AQ38268569-1FE76306-4D3D-4109-90D6-3A3EA5390F00Q38312076-339E5C26-95E1-4489-8678-F7A63E8DB622Q38390840-F897667A-4300-4E3D-90BA-C8656935BACAQ38776999-1B020FB5-BD20-49C5-921B-9B44856A086AQ39017641-77A7E858-170A-4D30-8E7F-66FB587B7CAAQ41541640-D28B0224-7DF8-4E0E-8045-BAD01083D2B8Q41613206-CECFD73E-C939-40C1-BBAD-BC8C7B64A84AQ42233957-7DB5BBDE-F1C9-4CF1-AB24-8D225DCD2DCAQ42398733-28F1DBA4-368F-48EB-AE38-E45992DCB4EAQ47698425-F0A58496-5FEB-4E9D-BF2E-6F2D3EF5791BQ48086718-1DACE6EE-C69A-4F48-BBEF-B16268D19EF6Q48095585-BCBD496B-6377-4BA0-9631-6E1EB75FD9ACQ48126437-C2522E3D-1E0F-4E90-8FBA-E20D87ACD2C2Q48214785-DA8025EB-423B-414F-B4F9-68087D18F778Q48327823-6CB8E375-280A-4586-9CBC-58C2CB571015Q50602051-3D01675F-2B8A-4465-8E04-7B4AF13B3E3AQ53116600-6DE4A025-7CEA-4F52-9739-22565270FC34Q54288828-0CCD1CD5-7B8A-4ACD-B49F-75C42733187FQ54336793-0ED5091B-5E3B-4BFB-8D61-61FDBF98F633Q55008637-DBFBD8BA-FC7F-44DE-9087-99C36FB273E4Q55381085-9EE7FB42-35F6-436A-8527-294FD2A12114Q57817700-1EC2568F-880F-4EF8-94BD-6EA252623FD0Q58799989-31141130-C72C-490F-832D-92AFFC54B2DC
P2860
The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The predictive role of skin ra ...... -analysis of published trials.
@en
type
label
The predictive role of skin ra ...... -analysis of published trials.
@en
prefLabel
The predictive role of skin ra ...... -analysis of published trials.
@en
P2093
P2860
P1433
P1476
The predictive role of skin ra ...... -analysis of published trials.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11523-013-0257-X
P577
2013-01-16T00:00:00Z
P6179
1011101886